Trade Summary

6 days ago, Aryeh Jason, serving as Dir at LIGAND PHARMACEUTICALS INC (LGND), sold 5,000 shares at $250.00 per share, for a total transaction value of $1,250,000.00. Following this transaction, Aryeh Jason now holds 102,580 shares of LGND.

This sale represents a 4.65% decrease in Aryeh Jason's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 10, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 12, 2026 at 5:27 PM ET, 2 days after the trade was made.

LIGAND PHARMACEUTICALS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.